Mediplantex National Pharmaceutical JSC (HNX:MED)

Vietnam flag Vietnam · Delayed Price · Currency is VND
25,200
0.00 (0.00%)
At close: Nov 20, 2025
5.00%
Market Cap 312.73B
Revenue (ttm) 355.39B
Net Income (ttm) 12.10B
Shares Out 12.41M
EPS (ttm) 975.46
PE Ratio 25.83
Forward PE n/a
Dividend 900.00 (3.57%)
Ex-Dividend Date Jul 16, 2025
Volume 100
Average Volume 24,678
Open 25,200
Previous Close 25,200
Day's Range 25,200 - 25,200
52-Week Range 22,600 - 28,600
Beta 0.14
RSI 54.84
Earnings Date Feb 3, 2026

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and ex... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 328
Stock Exchange Hanoi Stock Exchange
Ticker Symbol MED
Full Company Profile

Financial Performance

In 2024, HNX:MED's revenue was 443.14 billion, an increase of 10.03% compared to the previous year's 402.74 billion. Earnings were 15.25 billion, an increase of 29.83%.

Financial Statements

News

There is no news available yet.